Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

BACKGROUND & AIMS: The combination of ledipasvir and sofosbuvir has been approved for treatment of genotype 1 hepatitis C virus (HCV) infection, including an 8-week regimen for treatment-naïve patients without cirrhosis and a baseline level of HCV RNA <6 million IU/mL. We analyzed data from a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Gastroenterology
Egile Nagusiak: Terrault, Norah A., Zeuzem, Stefan, Di Bisceglie, Adrian M., Lim, Joseph K., Pockros, Paul J., Frazier, Lynn M., Kuo, Alexander, Lok, Anna S., Shiffman, Mitchell L., Ben Ari, Ziv, Akushevich, Lucy, Vainorius, Monika, Sulkowski, Mark S., Fried, Michael W., Nelson, David R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5300778/
https://ncbi.nlm.nih.gov/pubmed/27565882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2016.08.004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak